Ultragenyx Pharmaceutical Inc. buy SVB Leerink LLC
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€59.44
Performance (%)
11.85%
Price
05.06.26
€19.98
Summary
This prediction is currently active. The prediction currently has a performance of 11.85%. This prediction currently runs until 30.12.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.818% | -1.818% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Leerink Partners from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat